Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

BioNxt Solutions Inc C.BNXT

Alternate Symbol(s):  BNXTF

BioNxt Solutions Inc. is a bioscience company. The Company is focused on drug formulations and delivery systems, diagnostic screening tests, and new active pharmaceutical ingredient investment opportunities, including precision transdermal and oral dissolvable drug formulations; rapid, low-cost infectious disease and oral health screening tests; and standardization of emerging active pharmaceutical ingredients for neurological applications. The Company has research and development operations in North America and Europe, with an operational focus in Germany. The Company is also focused on regulatory approval and commercialization of medical products for European markets. Its diagnostic products include COVID-19 PCR Diagnostic Kit, Peri-Implantitis Oral Biosensor, and H1N1 (Swine Flu) and H5N1 (Avian Flu) Oral Biosensors. Its subsidiaries include XPhyto Laboratories Inc., Bunker Pflanzenextrakte GmbH, Vektor Pharma TF GmbH, BioNxt Europe GmbH, and 3a-diagnostics GmbH, among others.


CSE:BNXT - Post by User

Post by Franman184on May 03, 2021 7:23pm
171 Views
Post# 33120365

More Translation

More Translation
 Your test has been approved since April, when will you start using it? Sales in Germany are expected to start in May. We have now signed the pharmaceutical wholesaler Max Pharma as a sales partner. In addition, we are evaluating a pilot test beforehand, which we are now realizing together with a pharmacy near Frankfurt. We are currently expanding a sales network across Europe. So there are no more hurdles? At the moment it is not yet clear with whom and how we can settle accounts. With the rapid tests, the pharmacies have managed to settle accounts directly with the cash registers for the first time. That would be helpful for us too. So far this is not possible for us. We very much hope that there will be no complicated bureaucracy here.Can I also buy such a test as a private customer and carry it out at home?
  No, this is not a self-test for at home, we only sell to specialist staff. We are currently also developing a rapid RNA test that differs significantly from the existing rapid antigen test and should then also be applicable at home. However, this is still under development.Can I also buy such a test as a private customer and carry it out at home?
  No, this is not a self-test for at home, we only sell to specialist staff. We are currently also developing a rapid RNA test that differs significantly from the existing rapid antigen test and should then also be applicable at home. However, this is still under development.What market opportunities do you see for your PCR test?
  The pandemic is likely to stay with us for even longer. Therefore testing will remain an important tool. The market is huge, according to estimates by Allied Market Research, it should grow nearly 9 percent annually through 2023 and swell to $ 39.1 billion 
 What does your test even cost? We will announce the price with the market launch. We are within the scope of the competition, currently around 50 euros. But the market is turning very fast. How fast can you deliver? We can increase our capacities in a very short time. We produce at several locations in Germany, we do not see any delivery bottlenecks for raw materials.
<< Previous
Bullboard Posts
Next >>